sagent pharmaceuticals inc
(SGNT:Consolidated Issue Listed on NASDAQ Global Select )
|Age||Total Calculated Compensation||This person is connected to 11 board members in 1 different organizations across 2 different industries.|
See Board Relationships
Mr. James Sperans serves as the Managing Director of Morgan Stanley Alternative Investment Management, Inc. Mr. Sperans has been with Morgan Stanley Alternative since 2001. Previously, he was an entrepreneur, founding or co-founding four businesses, including two marketing automation services companies (TeamToolz and Nimblefish Technologies) and a New York-based private advisory firm. Prior to that, Mr. Sperans was a senior consultant of Bain & Company. In this capacity, ...
1901 North Roselle RoadPhone: 847-908-1600
Schaumburg, Illinois 60195
Board Members Memberships*
Harvard Business School
University of California Berkeley
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Friedhelm Blobel Ph.D.||Chief Executive Officer, President, Executive Director and Member of Business Development Committee|
SciClone Pharmaceuticals, Inc.
|Douglas A. Michels||Chief Executive Officer, President and Director|
OraSure Technologies, Inc.
|Yongfeng Zhang Ph.D.||Chief Executive Officer, Chief Science Officer and Director|
Amphastar Pharmaceuticals, Inc.
|Aijaz Tobaccowalla||Managing Director, Director, Member of Board Administrative & Share Transfer Committee, Member of Nomination & Remuneration Committee, Member of Corporate Social Responsibility Committee and Member of Audit Committee|
|Douglas L. Drysdale||Chairman, Chief Executive Officer and President|
Pernix Therapeutics Holdings, Inc.
|$814.6K||Compensation as of Fiscal Year 2014.|